+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

SARS-CoV-2 Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

  • PDF Icon

    Report

  • 78 Pages
  • February 2024
  • Region: Global
  • Prof Research
  • ID: 5730926
Description Jump to:

Quick Summary:

In an ever-evolving healthcare landscape, keeping abreast of developments in key therapeutic fields is crucial. If you are a business executive operating in, or investing in, the healthcare and pharmaceutical sector, our latest market report on the global SARS-CoV-2 Treatment market offers comprehensive, data-driven insights that you simply cannot afford to ignore. This report will be your definitive guide through the complex landscape of this rapidly growing sector and its key players.

Our report offers an in-depth perspective on the size and growth of this market from a global scale to the granular level of key regions, such as North America, South America, Asia & Pacific, Europe, and MEA. It also crucially provides competitive analysis, including company profiles and a SWOT analysis of leading and emerging players such as Gilead Sciences, Eli Lily, and Regeneron Pharmaceuticals. Take advantage of this opportunity to gain an informed perspective on the market, enhance your strategic planning, and outpace your competitors.

This report describes the global market size of SARS-CoV-2 Treatment from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029.

For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029.

This report covers the following regions:

  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA
The key countries for each region are also included, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes global key players of SARS-CoV-2 Treatment as well as some small players.

The information for each competitor includes:

  • Company Profile
  • Business Information
  • SWOT Analysis
  • Revenue, Gross Margin and Market Share

Types Segment

  • REGN-CoV2
  • Bamlanivimab
  • Remdesivir
  • dexamethasone

Companies Covered

  • Gilead Sciences
  • Eli Lily
  • Regeneron Pharmaceuticals
Base Year: 2024
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 COVID-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Sars-Cov-2 Treatment Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Sars-Cov-2 Treatment Market in North America (2019-2029)
8.1 Sars-Cov-2 Treatment Market Size
8.2 Sars-Cov-2 Treatment Market by End Use
8.3 Competition by Players/Suppliers
8.4 Sars-Cov-2 Treatment Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Sars-Cov-2 Treatment Market in South America (2019-2029)
9.1 Sars-Cov-2 Treatment Market Size
9.2 Sars-Cov-2 Treatment Market by End Use
9.3 Competition by Players/Suppliers
9.4 Sars-Cov-2 Treatment Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Sars-Cov-2 Treatment Market in Asia & Pacific (2019-2029)
10.1 Sars-Cov-2 Treatment Market Size
10.2 Sars-Cov-2 Treatment Market by End Use
10.3 Competition by Players/Suppliers
10.4 Sars-Cov-2 Treatment Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Sars-Cov-2 Treatment Market in Europe (2019-2029)
11.1 Sars-Cov-2 Treatment Market Size
11.2 Sars-Cov-2 Treatment Market by End Use
11.3 Competition by Players/Suppliers
11.4 Sars-Cov-2 Treatment Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Sars-Cov-2 Treatment Market in MEA (2019-2029)
12.1 Sars-Cov-2 Treatment Market Size
12.2 Sars-Cov-2 Treatment Market by End Use
12.3 Competition by Players/Suppliers
12.4 Sars-Cov-2 Treatment Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Sars-Cov-2 Treatment Market (2019-2024)
13.1 Sars-Cov-2 Treatment Market Size
13.2 Sars-Cov-2 Treatment Market by End Use
13.3 Competition by Players/Suppliers
13.4 Sars-Cov-2 Treatment Market Size by Type
Chapter 14 Global Sars-Cov-2 Treatment Market Forecast (2024-2029)
14.1 Sars-Cov-2 Treatment Market Size Forecast
14.2 Sars-Cov-2 Treatment Application Forecast
14.3 Competition by Players/Suppliers
14.4 Sars-Cov-2 Treatment Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Gilead Sciences
15.1.1 Company Profile
15.1.2 Main Business and SARS-CoV-2 Treatment Information
15.1.3 SWOT Analysis of Gilead Sciences
15.1.4 Gilead Sciences SARS-CoV-2 Treatment Revenue, Gross Margin and Market Share (2019-2024)
15.2 Eli Lily
15.2.1 Company Profile
15.2.2 Main Business and SARS-CoV-2 Treatment Information
15.2.3 SWOT Analysis of Eli Lily
15.2.4 Eli Lily SARS-CoV-2 Treatment Revenue, Gross Margin and Market Share (2019-2024)
15.3 Regeneron Pharmaceuticals
15.3.1 Company Profile
15.3.2 Main Business and SARS-CoV-2 Treatment Information
15.3.3 SWOT Analysis of Regeneron Pharmaceuticals
15.3.4 Regeneron Pharmaceuticals SARS-CoV-2 Treatment Revenue, Gross Margin and Market Share (2019-2024)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Sars-Cov-2 Treatment Report
Table Data Sources of Sars-Cov-2 Treatment Report
Table Major Assumptions of Sars-Cov-2 Treatment Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Sars-Cov-2 Treatment Picture
Table Sars-Cov-2 Treatment Classification
Table Sars-Cov-2 Treatment Applications
Table Drivers of Sars-Cov-2 Treatment Market
Table Restraints of Sars-Cov-2 Treatment Market
Table Opportunities of Sars-Cov-2 Treatment Market
Table Threats of Sars-Cov-2 Treatment Market
Table COVID-19 Impact For Sars-Cov-2 Treatment Market
Table Raw Materials Suppliers
Table Different Production Methods of Sars-Cov-2 Treatment
Table Cost Structure Analysis of Sars-Cov-2 Treatment
Table Key End Users
Table Latest News of Sars-Cov-2 Treatment Market
Table Merger and Acquisition
Table Planned/Future Project of Sars-Cov-2 Treatment Market
Table Policy of Sars-Cov-2 Treatment Market
Table 2019-2029 North America Sars-Cov-2 Treatment Market Size
Figure 2019-2029 North America Sars-Cov-2 Treatment Market Size and CAGR
Table 2019-2029 North America Sars-Cov-2 Treatment Market Size by Application
Table 2019-2024 North America Sars-Cov-2 Treatment Key Players Revenue
Table 2019-2024 North America Sars-Cov-2 Treatment Key Players Market Share
Table 2019-2029 North America Sars-Cov-2 Treatment Market Size by Type
Table 2019-2029 United States Sars-Cov-2 Treatment Market Size
Table 2019-2029 Canada Sars-Cov-2 Treatment Market Size
Table 2019-2029 Mexico Sars-Cov-2 Treatment Market Size
Table 2019-2029 South America Sars-Cov-2 Treatment Market Size
Figure 2019-2029 South America Sars-Cov-2 Treatment Market Size and CAGR
Table 2019-2029 South America Sars-Cov-2 Treatment Market Size by Application
Table 2019-2024 South America Sars-Cov-2 Treatment Key Players Revenue
Table 2019-2024 South America Sars-Cov-2 Treatment Key Players Market Share
Table 2019-2029 South America Sars-Cov-2 Treatment Market Size by Type
Table 2019-2029 Brazil Sars-Cov-2 Treatment Market Size
Table 2019-2029 Argentina Sars-Cov-2 Treatment Market Size
Table 2019-2029 Chile Sars-Cov-2 Treatment Market Size
Table 2019-2029 Peru Sars-Cov-2 Treatment Market Size
Table 2019-2029 Asia & Pacific Sars-Cov-2 Treatment Market Size
Figure 2019-2029 Asia & Pacific Sars-Cov-2 Treatment Market Size and CAGR
Table 2019-2029 Asia & Pacific Sars-Cov-2 Treatment Market Size by Application
Table 2019-2024 Asia & Pacific Sars-Cov-2 Treatment Key Players Revenue
Table 2019-2024 Asia & Pacific Sars-Cov-2 Treatment Key Players Market Share
Table 2019-2029 Asia & Pacific Sars-Cov-2 Treatment Market Size by Type
Table 2019-2029 China Sars-Cov-2 Treatment Market Size
Table 2019-2029 India Sars-Cov-2 Treatment Market Size
Table 2019-2029 Japan Sars-Cov-2 Treatment Market Size
Table 2019-2029 South Korea Sars-Cov-2 Treatment Market Size
Table 2019-2029 Southeast Asia Sars-Cov-2 Treatment Market Size
Table 2019-2029 Australia Sars-Cov-2 Treatment Market Size
Table 2019-2029 Europe Sars-Cov-2 Treatment Market Size
Figure 2019-2029 Europe Sars-Cov-2 Treatment Market Size and CAGR
Table 2019-2029 Europe Sars-Cov-2 Treatment Market Size by Application
Table 2019-2024 Europe Sars-Cov-2 Treatment Key Players Revenue
Table 2019-2024 Europe Sars-Cov-2 Treatment Key Players Market Share
Table 2019-2029 Europe Sars-Cov-2 Treatment Market Size by Type
Table 2019-2029 Germany Sars-Cov-2 Treatment Market Size
Table 2019-2029 France Sars-Cov-2 Treatment Market Size
Table 2019-2029 United Kingdom Sars-Cov-2 Treatment Market Size
Table 2019-2029 Italy Sars-Cov-2 Treatment Market Size
Table 2019-2029 Spain Sars-Cov-2 Treatment Market Size
Table 2019-2029 Belgium Sars-Cov-2 Treatment Market Size
Table 2019-2029 Netherlands Sars-Cov-2 Treatment Market Size
Table 2019-2029 Austria Sars-Cov-2 Treatment Market Size
Table 2019-2029 Poland Sars-Cov-2 Treatment Market Size
Table 2019-2029 Russia Sars-Cov-2 Treatment Market Size
Table 2019-2029 MEA Sars-Cov-2 Treatment Market Size
Figure 2019-2029 MEA Sars-Cov-2 Treatment Market Size and CAGR
Table 2019-2029 MEA Sars-Cov-2 Treatment Market Size by Application
Table 2019-2024 MEA Sars-Cov-2 Treatment Key Players Revenue
Table 2019-2024 MEA Sars-Cov-2 Treatment Key Players Market Share
Table 2019-2029 MEA Sars-Cov-2 Treatment Market Size by Type
Table 2019-2029 Egypt Sars-Cov-2 Treatment Market Size
Table 2019-2029 Israel Sars-Cov-2 Treatment Market Size
Table 2019-2029 South Africa Sars-Cov-2 Treatment Market Size
Table 2019-2029 Gulf Cooperation Council Countries Sars-Cov-2 Treatment Market Size
Table 2019-2029 Turkey Sars-Cov-2 Treatment Market Size
Table 2019-2024 Global Sars-Cov-2 Treatment Market Size by Region
Table 2019-2024 Global Sars-Cov-2 Treatment Market Size Share by Region
Table 2019-2024 Global Sars-Cov-2 Treatment Market Size by Application
Table 2019-2024 Global Sars-Cov-2 Treatment Market Share by Application
Table 2019-2024 Global Sars-Cov-2 Treatment Key Vendors Revenue
Figure 2019-2024 Global Sars-Cov-2 Treatment Market Size and Growth Rate
Table 2019-2024 Global Sars-Cov-2 Treatment Key Vendors Market Share
Table 2019-2024 Global Sars-Cov-2 Treatment Market Size by Type
Table 2019-2024 Global Sars-Cov-2 Treatment Market Share by Type
Table 2024-2029 Global Sars-Cov-2 Treatment Market Size by Region
Table 2024-2029 Global Sars-Cov-2 Treatment Market Size Share by Region
Table 2024-2029 Global Sars-Cov-2 Treatment Market Size by Application
Table 2024-2029 Global Sars-Cov-2 Treatment Market Share by Application
Table 2024-2029 Global Sars-Cov-2 Treatment Key Vendors Revenue
Figure 2024-2029 Global Sars-Cov-2 Treatment Market Size and Growth Rate
Table 2024-2029 Global Sars-Cov-2 Treatment Key Vendors Market Share
Table 2024-2029 Global Sars-Cov-2 Treatment Market Size by Type
Table 2024-2029 Sars-Cov-2 Treatment Global Market Share by Type

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Gilead Sciences
  • Eli Lily
  • Regeneron Pharmaceuticals

Methodology

Loading
LOADING...

Related Topics

Related Reports

COVID-19 - Pipeline Insight, 2024 - Product Image

COVID-19 - Pipeline Insight, 2024

  • Drug Pipelines
  • 200 Pages
  • Global
From
Coronavirus-3C-like-proteinase inhibitors - Pipeline Insight, 2024 - Product Image

Coronavirus-3C-like-proteinase inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • 60 Pages
  • Global
From
COVID-19 Nucleic Acid Amplification Tests (NAATs) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update - Product Image

COVID-19 Nucleic Acid Amplification Tests (NAATs) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

  • Report
  • 22 Pages
  • Global
From
Remdesivir Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Remdesivir Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Antiviral Combination Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Antiviral Combination Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 180 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.